Follow the Bausch & Lomb Corp stock price and the full management transaction log of the company, a listed equity based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Operating in the Health Care sector, Bausch & Lomb Corp has logged 131 insider filings. Market capitalisation: €6.1bn. The latest transaction was reported on 16 June 2026 (Retenue fiscale). Among the most active insiders: ROBERTSON RUSSEL C. All data is free.
131
Insider Decl.
0
Thresholds
€478,845
2 ops.
Buy Volume
€640m
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Bausch & Lomb Corp Buy (bullish), based on 12 analysts. Average price target: US$17.88.
39Σ signal
Buys €478,845€640m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 21,338 of 25,484 companies
27.8
score / 100
Value
25
Quality
31
FCF yld-1.1%
Earn yld-5.9%
EV/EBITDA21.3x
ROE-3.3%
Gross mgn60%
Net mgn-7.1%
Debt/EBITDA9.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2,524 shares@ US$17.8329.5% of flowCommon Shares, No Par ValueSEC:0001127602-24-030058:0
25 of 131 declarations
About Bausch & Lomb Corp
Bausch & Lomb Corp is a company focused on eye care, providing products such as contact lenses and care solutions. It is listed on NASDAQ under the ticker BLCO.